Dr. Kadam is a Neuroscience Research Scientist, Associate Professor of Neurology and Director of the Pre-clinical In-vivo Electrophysiology Core, Kennedy Krieger Institute.
Dr. Shilpa Kadam's laboratory is focused on translational neuroscience research investigating the mechanims underlying epileptogenesis in models of developmental disabilities with the goal to discover new interventional therapies. Her laboratory utilizes a novel systems neuroscience approach using in-vivo qEEG in models of developmental neurological disorders. She has successfully established a developmental model of ischemic neonatal seizures and characterised the seizures for their non-responsiveness to traditional first-line GABA agonists with the goal to both find novel alternative therapies and also prevent the occurrence of long-term co-morbidities commonly associated with the disorder. Her research has been funded by the Epilepsy Foundation and the NICHD.
Strong Collaborations + SYNGAP1 Research =
Accelerated Development of Better Treatments
West Bank, Sheffield, UK